Discover
RPRX
Royalty Pharma plc
55.78
2 x 51.29
2 x 60.31
bid
ask
-
0.29
0.52%
2 @ 04:22 AM
56.23 +0.45 (0.81%)
| Ytd | 44.36% | |
| 1y | 54.13% |
55.34
day range
56.30
34.08
52 week range
57.22
| Open | 56.09 | Prev Close | 56.07 | Low | 55.34 | High | 56.30 | Mkt Cap | 32.12B |
| Vol | 2.41M | Avg Vol | 3.71M | EPS | 1.90 | P/E | 29.36 | Forward P/E | 9.99 |
| Beta | 0.42 | Short Ratio | 2.66 | Inst. Own | 88.07% | Dividend | 0.94 | Div Yield | 1.65 |
| Ex Div Date | 05-15 | Earning | 08-05 | 50-d Avg | 53.07 | 200-d Avg | 44.11 | 1yr Est | 59.25 |
| Income Statement | |||
| Total Revenue | 630.58M | ||
| Revenues (USD) | 630.58M | ||
| Gross Profit | 630.58M | ||
| Operating Expenses | 67.54M | ||
| Research and Development Expense | 39.79M | ||
| Selling, General and Administrative Expense | 159.49M | ||
| Operating Income | 563.04M | ||
| Interest Expense | 93.72M | ||
| Net Income | 294.69M | ||
| Net Income Common Stock | 294.69M | ||
| Net Income Common Stock (USD) | 294.69M | ||
| Consolidated Income | 468.26M | ||
| Net Income to Non-Controlling Interests | 173.57M | ||
| Earnings per Basic Share | 0.67 | ||
| Earnings per Basic Share (USD) | 0.67 | ||
| Earnings per Diluted Share | 0.67 | ||
| Dividends per Basic Common Share | 0.24 | ||
| Earning Before Interest & Taxes (EBIT) | 388.41M | ||
| Earning Before Interest & Taxes (USD) | 388.41M | ||
| Weighted Average Shares | 436.79M | ||
| Weighted Average Shares Diluted | 556.84M | ||
| Balance Sheet | |||
| Cash and Equivalents | 586.40M | ||
| Cash and Equivalents (USD) | 586.40M | ||
| Investments | 18.19B | ||
| Investments Current | 801.74M | ||
| Investments Non-Current | 17.39B | ||
| Trade and Non-Trade Receivables | 27.51M | ||
| Current Assets | 1.43B | ||
| Total Assets | 19.82B | ||
| Debt Current | 380.00M | ||
| Total Debt | 8.96B | ||
| Current Liabilities | 535.68M | ||
| Debt Non-Current | 8.58B | ||
| Total Liabilities | 9.88B | ||
| Accumulated Retained Earnings (Deficit) | 2.51B | ||
| Shareholders Equity | 9.94B | ||
| Shareholders Equity (USD) | 9.94B | ||
| Assets Non-Current | 18.39B | ||
| Total Debt (USD) | 8.96B | ||
| Goodwill and Intangible Assets | 924.63M | ||
| Liabilities Non-Current | 9.34B | ||
| Trade and Non-Trade Payables | 25.48M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | -272.67M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -32.30M | ||
| Capital Expenditure | -50.00M | ||
| Issuance (Purchase) of Equity Shares | -50.10M | ||
| Payment of Dividends & Other Cash Distributions | -104.49M | ||
| Net Cash Flow from Investing | -477.86M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -427.86M | ||
| Net Cash Flow from Operations | 718.23M | ||